Role of the ERK/MAPK pathway in intestine development and homeostasis
Role of the ERK/MAPK pathway in intestine development and homeostasis
批准号:
RGPIN-2016-05837
负责人:
Charron, Jean
金额:
$2.26万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-01-01 至 2019-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Organ formation relies on multiple cellular processes that imply paracrine signaling mediated by cell-cell contacts or secreted ligands. How signal instructions are interpreted to ultimately control cell fate and morphogenesis is a central question in biology. The mitogen-activated protein kinase (MAPK) signaling pathways are involved in signal transduction through transmembrane receptors. The ERK/MAPK pathway constitutes the major pathway involved in the tight control of cell proliferation, differentiation and survival. It transduces the effects of many growth factors implicated in cell fate determination in several organisms. In mammals, the extracellular-signal-regulated kinases ERK1 and ERK2 are activated by the dual-specificity (serine/threonine and tyrosine) kinases MEK1 and MEK2. MEK1 and MEK2 played crucial and unique role in signal transduction during development. The loss of Mek1 function results in embryonic death at mid-gestation due to defects in growth and morphogenesis of the placenta whereas Mek2 mutant mice do not present phenotype. Using a Mek1 conditional allele and lineage-specific Cre mouse lines, we have shown that both MEK1 and MEK2 are required for correct neurogenesis, skin formation, lymphopoiesis, erythropoiesis, lung and kidney development and male fertility, revealing the broad role of the ERK/MAPK cascade throughout life. When MEK function is specifically ablated in the epithelium, gastrointestinal (GI) defects occur with anorectal malformations and small intestine shortening. The proliferation and differentiation of the intestinal epithelium is also compromised. The enterocytes present a specific extension of their apical membrane associated with the loss of CDX2 expression indicating abnormal cell polarity. Finally, expression of stem cell markers was increased suggesting perturbations in the stem cell niche. Altogether, these data underscore the importance of the ERK/MAPK pathway in intestinal epithelium. We hypothesize that the ERK/MAPK cascade is essential to transduce instructive signals during gut organogenesis and homeostasis. The central objective of our research program is to investigate the genetic and molecular mechanisms driven by the ERK/MAPK pathway that are involved in gut development and cell behavior in order to elucidate how Mek1 and Mek2 genes coordinate GI tract morphogenesis. To reach these goals, we propose to define the role of the ERK/MAPK pathway: ***1. In gastrointestinal epithelial cell proliferation and differentiation. ***2. In enterocyte cell polarity. ***3. In the maintenance of the intestinal epithelial stem cell niche.**
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of the ERK/MAPK pathway in intestine development and homeostasis
-
批准号:RGPIN-2016-05837
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.26万
-
财政年份:2021
-
负责人:Charron, Jean
-
依托单位:
Role of the ERK/MAPK pathway in intestine development and homeostasis
-
批准号:RGPIN-2016-05837
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.26万
-
财政年份:2020
-
负责人:Charron, Jean
-
依托单位:
Role of the ERK/MAPK pathway in intestine development and homeostasis
-
批准号:RGPIN-2016-05837
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.26万
-
财政年份:2019
-
负责人:Charron, Jean
-
依托单位:
Role of the ERK/MAPK pathway in intestine development and homeostasis
-
批准号:RGPIN-2016-05837
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.26万
-
财政年份:2017
-
负责人:Charron, Jean
-
依托单位:
Role of the ERK/MAPK pathway in intestine development and homeostasis
-
批准号:RGPIN-2016-05837
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.26万
-
财政年份:2016
-
负责人:Charron, Jean
-
依托单位:
Molecular mechanisms of N-myc gene regulation during mammalian embryonic development
-
批准号:194557-2012
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$1.89万
-
财政年份:2012
-
负责人:Charron, Jean
-
依托单位:
Molecular mechanisms of N-myc gene regulation during mammalian embroyonic development
-
批准号:194557-2006
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.07万
-
财政年份:2010
-
负责人:Charron, Jean
-
依托单位:
Molecular mechanisms of N-myc gene regulation during mammalian embroyonic development
-
批准号:194557-2006
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.07万
-
财政年份:2009
-
负责人:Charron, Jean
-
依托单位:
Molecular mechanisms of N-myc gene regulation during mammalian embroyonic development
-
批准号:194557-2006
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.07万
-
财政年份:2008
-
负责人:Charron, Jean
-
依托单位:
Molecular mechanisms of N-myc gene regulation during mammalian embroyonic development
-
批准号:194557-2006
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.07万
-
财政年份:2006
-
负责人:Charron, Jean
-
依托单位:
国内基金
海外基金
登录
查看更多内容
EGFR/MAPK/ERK信号通路介导肿瘤相关成纤维细胞分泌TNC导致复发/转移头颈部鳞状细胞癌免疫治疗抵抗的机制研究
-
批准号:JCZRLH202600215
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
肠道菌群代谢物5-HTP负调控MAPK/ERK通路改善孤独症样行为的机制研究
-
批准号:JCZRQNB202600954
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于PD-1/PD-L1调控PI3K/AKT与MAPK/ERK通路探讨栀子苷-大黄素配伍改善脓毒症免疫抑制的作用
-
批准号:2026JJ81015
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谢伶俐
-
依托单位:
基于PTEN/MAPK/ERK轴的暖巢助孕方干预POI线粒体功能障碍研究
-
批准号:2026JJ81878
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈镇
-
依托单位:
基于谱效关系和MAPK/ERK信号的吴茱萸酒制前后配伍当归治疗原发性痛经物质基础和作用机制研究
-
批准号:2026JJ82685
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘叶倩
-
依托单位:
GnRH受体信号通路异常通过 MAPK/ERK轴诱导早发性卵巢功能不全中颗粒细胞凋亡及卵泡闭锁的机制研究
-
批准号:2026JJ82506
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:黄建美
-
依托单位:
生育三烯酚调节RAS-ERK-MAPK通路促糖尿病溃疡愈合的机制研究
-
批准号:2025JJ80977
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:兰宏伟
-
依托单位:
基于 MAPK/ERK 信号通路 RDN 调控 miR-133
改善 SHR 大鼠急性心肌梗死的机制研究
-
批准号:TGD24H020002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:蔡晓娜
-
依托单位:
白细胞介素-17通过ERK/MAPK通路调控猪小肠上皮细胞
分化的机制研究
-
批准号:2024JJ6310
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:尹蓝梅
-
依托单位:
基于“肾主骨生髓”理论探讨生骨再造丸上调MAPK/ERK1/2信号通路促进BMSCS成骨分化干预骨质疏松症的机制研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:郭成龙
-
依托单位: